Get started
Author

Daniel Rupp

HIV-1 Antagonism of CD317 Is Species Specific and Involves Vpu-Mediated Proteasomal Degradation of the Restriction Factor
2009 · Christine Goffinet, Ina Allespach, et al. · Cell Host & Microbe · 263
PDF
Evidence for Novel Hepaciviruses in Rodents
2013 · Jan Felix Drexler, Victor Max Corman, et al. · PLoS Pathogens · 214
PDF
Geno2pheno[HCV] – A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents
2016 · Prabhav Kalaghatgi, Anna Maria Sikorski, et al. · PLoS ONE · 119
PDF
Antagonism of CD317 Restriction of Human Immunodeficiency Virus Type 1 (HIV-1) Particle Release and Depletion of CD317 Are Separable Activities of HIV-1 Vpu
2010 · Christine Goffinet, Stefanie Homann, et al. · Journal of Virology · 69
Identification of HNRNPK as Regulator of Hepatitis C Virus Particle Production
2015 · Marion Poenisch, Philippe Metz, et al. · PLoS Pathogens · 61
PDF
Targets for Antiviral Therapy of Hepatitis C
2014 · Daniel Rupp, Ralf Bartenschlager · Seminars in Liver Disease · 45
PDF
Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys
2015 · Stefan Mockenhaupt, Stefanie Grosse, et al. · Proceedings of the National Academy of Sciences · 39
Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis
2017 · Julia Pollmann, Jana-Julia Götz, et al. · Journal of Hepatology · 19
Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-region
2014 · William L. Irving, Daniel Rupp, et al. · Antiviral Research · 12
PDF
TALEN/CRISPR-mediated engineering of a promoterless anti-viral RNAi hairpin into an endogenous miRNA locus
2016 · Elena Senís, Stefan Mockenhaupt, et al. · Nucleic Acids Research · 11
PDF
Immune-mediated effects targeting hepatitis C virus in a syngeneic replicon cell transplantation mouse model
2017 · Sepideh Levander, Fredrik Holmström, et al. · Gut · 6
PDF
Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy
2016 · Julia Dietz, Daniel Rupp, et al. · PLoS ONE · 6
PDF
Poor Performance of Bioinformatics Programs for Genotypic Prediction of Coreceptor Usage of HIV-1 Group O Isolates
2010 · Daniel Rupp, Silvia Geuenich, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 6
Retrieval of a fractured angioplasty guidewire after percutaneous retrograde revascularization of coronary chronic total occlusion
2017 · Stefan Baumann, Daniel Rupp, et al. · Coronary Artery Disease · 5
P0818 : Analysis of NS3 protease resistance-associated variants and phenotypes for the prediction of treatment response to HCV triple therapy
2015 · J. Dietz, D. Rupp, et al. · Journal of Hepatology · 1
Untersuchung von Resistenzmutationen innerhalb der NS3 Protease zur Vorhersage des Therapieausgangs der HCV Triple-Therapie
2015 · J Dietz, D Rupp, et al. · Zeitschrift für Gastroenterologie
1189 Next Generation Sequencing and in Vitro Characterization Reveal Population Bottlenecks and Fixation of Selectively Neutral Mutations Occurs Post-bi 201335 Therapy
2013 · W. Irving, D. Rupp, et al. · Journal of Hepatology
HIV-1 antagonism of CD317/tetherin is species-specific and involves Vpu-mediated proteasomal degradation of the intrinsic immunity factor
2009 · Christine Goffinet, Ina Allespach, et al. · Retrovirology
PDF
Works count: 20
Citation count: 877
H-index: 10
I10-index: 10
Year
Topic
Type